GLG Partners LP cut its stake in shares of Cigna Corporation (NYSE:CI) by 4.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,992 shares of the health services provider’s stock after selling 1,008 shares during the quarter. GLG Partners LP’s holdings in Cigna Corporation were worth $4,016,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently made changes to their positions in the company. Guardian Life Insurance Co. of America boosted its holdings in shares of Cigna Corporation by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after purchasing an additional 7 shares in the last quarter. Pacer Advisors Inc. increased its position in shares of Cigna Corporation by 3.0% during the 2nd quarter. Pacer Advisors Inc. now owns 5,581 shares of the health services provider’s stock valued at $934,000 after purchasing an additional 165 shares during the last quarter. Norinchukin Bank The increased its position in shares of Cigna Corporation by 6.4% during the 2nd quarter. Norinchukin Bank The now owns 17,766 shares of the health services provider’s stock valued at $2,974,000 after purchasing an additional 1,062 shares during the last quarter. Schroder Investment Management Group increased its position in shares of Cigna Corporation by 1,794.4% during the 2nd quarter. Schroder Investment Management Group now owns 187,770 shares of the health services provider’s stock valued at $31,301,000 after purchasing an additional 177,858 shares during the last quarter. Finally, Seven Eight Capital LP raised its holdings in shares of Cigna Corporation by 504.4% during the 2nd quarter. Seven Eight Capital LP now owns 27,200 shares of the health services provider’s stock valued at $4,553,000 after buying an additional 22,700 shares in the last quarter. Institutional investors and hedge funds own 87.94% of the company’s stock.

In other Cigna Corporation news, Director William D. Zollars sold 1,232 shares of the stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total transaction of $230,667.36. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Chairman Isaiah Harris, Jr. sold 247 shares of the stock in a transaction on Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total value of $45,761.69. The disclosure for this sale can be found here. Insiders sold 70,653 shares of company stock valued at $12,437,684 in the last three months. 1.30% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: “Cigna Corporation (CI) Shares Sold by GLG Partners LP” was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/02/cigna-corporation-ci-shares-sold-by-glg-partners-lp.html.

A number of analysts recently weighed in on the company. UBS AG restated a “buy” rating and issued a $186.00 target price (up previously from $181.00) on shares of Cigna Corporation in a research report on Monday, June 5th. Morgan Stanley assumed coverage on Cigna Corporation in a research note on Tuesday, June 6th. They issued an “overweight” rating and a $184.00 target price for the company. Jefferies Group LLC reiterated a “buy” rating and set a $183.00 price target on shares of Cigna Corporation in a research report on Thursday, June 8th. Credit Suisse Group began coverage on shares of Cigna Corporation in a research report on Monday, June 12th. They set an “outperform” rating and a $185.00 price target on the stock. Finally, Royal Bank Of Canada reissued a “buy” rating and set a $177.00 price target on shares of Cigna Corporation in a research note on Tuesday, June 13th. Two investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Cigna Corporation presently has a consensus rating of “Buy” and a consensus target price of $187.67.

Shares of Cigna Corporation (CI) traded down 0.20% on Monday, reaching $186.57. The company had a trading volume of 302,481 shares. The stock’s 50 day moving average is $180.07 and its 200 day moving average is $165.77. Cigna Corporation has a 52 week low of $115.03 and a 52 week high of $188.36. The firm has a market capitalization of $46.97 billion, a price-to-earnings ratio of 21.53 and a beta of 0.43.

Cigna Corporation (NYSE:CI) last posted its earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, beating analysts’ consensus estimates of $2.48 by $0.43. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The business had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. During the same quarter last year, the firm posted $1.98 EPS. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, equities analysts anticipate that Cigna Corporation will post $10.03 EPS for the current year.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.